Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

Jan 28, 2015

30071_dirs_2015-01-28_3735d596-f4fd-477f-a1cc-50fd243eb932.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-01-26

Reporting Person: PACE GARY W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-01-26 ResMed Common Stock M 48000 $16.498 Acquired 141158 Indirect
2015-01-26 ResMed Common Stock S 48000 $66.767 Disposed 93158 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-01-26 ResMed Common Stock Options $16.498 M 48000 Disposed 2015-07-01 ResMed Commmon Stock (48000) Indirect

Footnotes

F1: Represents first date options became exercisable.

F2: This transaction was executed in multiple trades at prices ranging from $66.53 to $66.97. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.